OmniAb, Inc. (OABI)
5.105
-0.12
(-2.39%)
USD |
NASDAQ |
Oct 30, 16:00
5.11
0.00 (0.00%)
After-Hours: 20:00
OmniAb Cash from Investing (Quarterly) : -7.622M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.622M |
| March 31, 2026 | 8.436M |
| December 31, 2025 | 2.711M |
| September 30, 2025 | -7.665M |
| June 30, 2025 | 12.30M |
| March 31, 2025 | -0.878M |
| December 31, 2024 | 0.385M |
| September 30, 2024 | 4.449M |
| June 30, 2024 | 13.11M |
| March 31, 2024 | 19.94M |
| December 31, 2023 | 4.73M |
| Date | Value |
|---|---|
| September 30, 2023 | 6.286M |
| June 30, 2023 | 7.78M |
| March 31, 2023 | -37.17M |
| December 31, 2022 | -60.20M |
| September 30, 2022 | -4.875M |
| June 30, 2022 | -4.29M |
| March 31, 2022 | -3.947M |
| December 31, 2021 | 231.72M |
| September 30, 2021 | -235.75M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | -559.00M |
| Champions Oncology, Inc. | -0.055M |
| Medpace Holdings, Inc. | -20.14M |
| Charles River Laboratories International, Inc. | 28.10M |
| Avantor, Inc. | -38.50M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.679M |
| Cash from Financing (Quarterly) | 0.233M |
| Free Cash Flow | -18.14M |
| Free Cash Flow Per Share (Quarterly) | 0.0199 |
| Free Cash Flow to Equity (Quarterly) | 3.326M |
| Free Cash Flow to Firm (Quarterly) | 2.569M |
| Free Cash Flow Yield | -2.85% |